2.650EUR+0.38%Mkt Cap: 11.71M EURP/E: 15.50Last update: 2026-05-29
Medicon Hellas S.A. operates in the diagnostics industry that offers instruments, tests, and procedures to clinical and research labs in Greece and internationally. It manufactures, imports, and provides diagnostic and p…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap11.71M EUR
Enterprise Value12.38M EUR
Revenue (TTM)18.54M EUR
Gross Profit13.06M EUR
Net Income (TTM)1.86M EUR
Revenue/Share4.195 EUR
Last Price2.650 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees151
CountryGR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)15.50
P/E (Forward)—
PEG—
EV/EBITDA3.60
EV/Revenue0.67
P/S0.63
P/B0.61
EPS (TTM)0.17
EPS (Forward)—
52W Range
2.21062% of range2.920
52W High2.920 EUR
52W Low2.210 EUR
Profitability
Gross Margin70.43%
Oper. Margin10.21%
EBITDA Margin18.57%
Profit Margin10.23%
ROE9.63%
ROA4.31%
Growth
Revenue Growth4.90%
Earnings Growth202.20%
Cash Flow & Leverage
Operating CF1.16M EUR
CapEx (TTM)—
FCF Margin1.97%
FCF Yield3.11%
Net Debt401.44K EUR
Net Debt/EBITDA0.12
Balance Sheet
Debt/Equity48.61
Current Ratio5.75
Quick Ratio4.97
Book Value/Sh4.323 EUR
Cash/Share2.039 EUR
Dividends
Fwd Div Rate0.1300 EUR
Trail. Div Rate0.1300 EUR
Div. Yield4.92%
5Y Avg Yield8.00%
Payout Ratio—
Ex-Div DateJul 7, 2025
Pay DateJul 11, 2001
Splits
Last Split22.03045:21.03045
Split DateMar 4, 2015
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.42M
Float—
Insiders44.74%
Institutions0.00%
Technical
SMA 502.497 (+6.1%)
SMA 2002.542 (+4.2%)
Beta0.45
S&P 52W Chg27.94%
Avg Vol (30d)2.45K
Avg Vol (10d)1.74K
Technical Indicators
RSI (14)60.2
MACD0.0420
MACD Signal0.0352
MACD Hist.+0.0068
BB Upper2.698 EUR
BB Middle2.570 EUR
BB Lower2.441 EUR
BB Width10.02%
ATR (14)0.0583 EUR
Vol Ratio (20d)0.61x